U.S. Markets close in 35 mins

Dendreon Corp. (DNDN) Soars: Stock Rises 14.9%

Zacks Equity Research

Dendreon Corp. (DNDN) was a big mover last session, as its shares rose nearly 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $2.65 to $3.01 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Dendreon currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Emergent BioSolutions, Inc. (EBS) and Biogen Idec Inc. (BIIB). While Emergent BioSolutions sports a Zacks Rank #1 (Strong Buy), Cambrex and Biogen carry a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

DENDREON CP (DNDN): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report


(BIIB): Free Stock Analysis Report

Zacks Investment Research